Rocks, O
Available at Accessed 11/10/21

Ingredients cyclopentasiloxane, dimethicone crosspolymer, pentaerythrityl tetraethylhexanoate, isononyl isononanoate, prunus amygdalus dulcis (sweet almond) oil, helianthus annuus (sunflower) seed oil, caprylic/capric triglyceride, argania spinosa kernel oil, dimethiconol, tetrahexyldecyl ascorbate, bisabolol, borago officinalis seed oil, linoleic acid, c12-15 alkyl benzoate, caprylyl glycol, 1,2-hexanediol, bht, ethylhexyl palmitate, dimethicone/vinyl dimethicone crosspolymer, parfum/fragrance, oleic acid, tribehenin, peg-8, linum usitatissimum (linseed) seed oil, palmitic acid, tocopherol, stearic acid, ceramide ng, peg-10 rapeseed sterol, butylene glycol, linolenic acid, magnolia officinalis bark extract, oenothera biennis (evening primrose) oil, ascorbyl palmitate, lactic acid, linalool, benzyl benzoate, silica dimethyl silylate, citronellol, glycyrrhiza uralensis (licorice) root extract, benzyl salicylate, butylphenyl methylpropional, hydroxycitronellal, hexyl cinnamal, limonene, ascorbic acid, citric acid, farnesol, aqua/water/eau, phenoxyethanol, glycyrrhiza glabra (licorice) rhizome/root extract, glycyrrhiza glabra (licorice) root extract, sodium hyaluronate, hexylene glycol, palmitoyl hexapeptide-12, ilomastat, cichorium intybus (chicory) root extract, ethylhexylglycerin

It does not reduce circulating DHT levels or prevent DHT from binding to follicle receptors
Tirzepatide compared to other GLP-1 medications Tirzepatide is one of several GLP-1 receptor agonists available for weight management and metabolic health
Neurotoxicity Research